Metabolic clinic atlas: Organization of care for children with inherited metabolic disease in Canada

on behalf of the Canadian Inherited Metabolic Diseases Research Network

Résultat de recherche: Chapter

3 Citations (Scopus)

Résumé

Introduction: Nearly all children in Canada with an inherited metabolic disease (IMD) are treated at one of the country’s Hereditary Metabolic Disease Treatment Centres. We sought to understand the system of care for paediatric IMD patients in Canada in order to identify sources of variation and inform future research priorities. Methods: Treatment centres were contacted by email and invited to complete a web-based survey. The questionnaire addressed, for each centre, the population size served and scope of practice, available human resources and clinic services and research capacity. Survey responses were analyzed descriptively. Results: We received responses from 13 of the 14 treatment centres invited to participate. These centres represent at least 85% of the Canadian population, with over half of the centres located in southern Ontario and Quebec. All centres reported paediatric patients with IMDs as their main patient population. A variety of dedicated staff was identified; every centre reported having at least one physician and one dietician. The most common ancillary services available included telehealth (11/12 respondents) and biochemical genetic laboratory testing (10/12), with a high variability of access to on-site laboratory tests. A majority of centres indicated access to additional off-site services, but barriers to these were reported. All but one centre indicated previous experience with research. Conclusions: The variation we identified in the organization of care highlights the need to investigate the association between practice differences and health outcomes for paediatric IMD patients to inform policies that establish equitable access to services that are beneficial.

Langue d'origineEnglish
Titre de la publication principaleJIMD Reports
Maison d'édition Springer
Pages15-22
Nombre de pages8
DOI
Statut de publicationPublished - 2015

Séries de publication

PrénomJIMD Reports
Volume21
ISSN (imprimé)2192-8304
ISSN (électronique)2192-8312

Note bibliographique

Funding Information:
Jennifer MacKenzie has clinical trials funded by BioMarin and Shire and has received honoraria and/or travel funding from Shire, Genzyme, BioMarin and Actelion.

Funding Information:
The following authors declare additional funding (not related to the financial support or subject matter of the manuscript): Sarah Dyack has received honoraria, research and/or travel funds from Shire and/or Genzyme Corporation.

Funding Information:
Cheryl Rockman-Greenberg received research grant support, but no personal financial compensation, for clinical trials from BioMarin, Genzyme Canada, Shire Human Genetic Therapies (Canada) Inc. and Alexion Pharmaceuticals. She also received honoraria from Alexion for industry-sponsored lectures, symposia and webinars and travel reimbursement and consultation fees from the Actelion National Advisory Board for Niemann-Pick C disease.

Funding Information:
This work was supported by the Canadian Institutes of Health Research (CIHR) [Grant # TR3-119195].

Publisher Copyright:
© 2014, SSIEM and Springer-Verlag Berlin Heidelberg.

ASJC Scopus Subject Areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

PubMed: MeSH publication types

  • Journal Article

Empreinte numérique

Plonger dans les sujets de recherche 'Metabolic clinic atlas: Organization of care for children with inherited metabolic disease in Canada'. Ensemble, ils forment une empreinte numérique unique.

Citer